Evidence map›Paper›PMID 32039218›Full record

SynthesisFrontiers in medicine2019

Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis.

Kata Szemes, Alexandra Soós, Péter Hegyi, Nelli Farkas, Adrienn Erős, Bálint Erőss, Emese Mezősi, Zsolt Szakács, Katalin Márta, Patrícia Sarlós

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. A review of the therapeutic management of ulcerative colitis.Therapeutic advances in gastroenterology · 2022
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kata SzemesFirst Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
Alexandra SoósInstitute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Péter HegyiFirst Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
Nelli FarkasInstitute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Adrienn ErősInstitute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Bálint ErőssInstitute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Emese MezősiFirst Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
Zsolt SzakácsInstitute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Katalin MártaInstitute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Patrícia SarlósFirst Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
University of Pecs · HUUniversity of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

colectomycyclosporineinfliximabmeta-analysissteroid-refractoryulcerative colitis

Identifiers

PMID32039218
PMCPMC6985460
OpenAlexW3002547631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.